Emily Z. Keung, MD, AM, FACS, FSSO

Peer-Reviewed Articles

1. Tomczak K, Patel MS, Bhalla AD, Peterson CB, Landers SM, Callahan SC, Zhang D, Wong J, Landry JP, Lazar AJ, Livingston JA, Guadagnolo BA, Lyu HG, Lillemoe H, Roland CL, Keung EZ, Scally CP, Hunt KK, McCutcheon IE, Slopis JM, Gu J, Scheet P, Wang L, Rai K, Torres KE. Plasma DNA methylation-based biomarkers for MPNST detection in patients with neurofibromatosis type 1 64(1):44-45, 2025.
2. Nasr LF, Zoghbi M, Lazcano R, Nakazawa M, Bishop AJ, Farooqi A, Mitra D, Guadagnolo BA, Benjamin R, Patel S, Ravi V, Araujo DM, Livingston A, Zarzour MA, Conley AP, Ratan R, Somaiah N, Lazar AJ, Roland C, Keung EZ, Nassif Haddad EF. High-Grade Pleomorphic Sarcomas Treated with Immune Checkpoint Blockade: The MD Anderson Cancer Center Experience. Cancers 16(9):1763, 2024. e-Pub 2024. PMID: 38730715.
3. Roland CL, Nassif EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Parra ER, Limb CF, Gaudagnolo BA, Bishop AJ, Ingram D, Wani K, Crosby S, Al Rawi AN, Mathew G, Duncan S, Burton E, Ajami N, Torres KE, Hunt KK, Feig BW, Scally CP, Witt RG, Traweek R, Cope B, Lewis V, Bird J, Wu CC, Mohammad M, Chu RA, Zhang JH, Fridman WF, Damania A, Blay JY, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Shaw K, Lin P, Moon B, Satcher R, Wistuba I, Futreal A, Wargo JA, Somaiah N. Neoadjuvant immune checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/trunk undifferentiated pleomorphic sarcoma. Nature Cancer 5:625-641, 2024. e-Pub 2024.
4. Award A, Pal K, Yevich S, Kuban JD, Tam A, Odisio BC, Gupta S, Habibollahi P, Bishop AJ, Conley AP, Somaiah N, Araujo D, Zarzour MA. Safety and efficacy of percutaneous thermal ablation for soft tissue sarcoma metastases to the liver. Cancer, 2024. e-Pub 2024. PMID: 38642369.
5. Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. High community-level social vulnerability is associated with worse recurrence-free survival after resection of extremity and truncal soft tissue sarcoma. Annals of Surgical Oncology 31(6):4138-4147, 2024. e-Pub 2024. PMID: 38396039.
6. Traweek RS, Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF. ASO visual abstract: High community-level social vulnerability is associated with worse recurrence-free survival following resection of extremity and truncal soft-tissue sarcoma. Annals of Surgical Oncology 31(6):4150-4151, 2024. e-Pub 2024. PMID: 38396039.
7. Bishop AJ, Mitra D, Farooqi A, Swanson DM, Hempel C, Willis T, Pearlnath C, Wang WL, Ratan R, Somaiah N, Benjamin BS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Guadagnolo BA. Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcoma (HYPORT-STS): updated local control, late-toxicities and patient-reported outcomes. Cancer, 2024. e-Pub 2024.
8. Gingrich A, Wangsiricharoen S, Torres, MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. ASO visual abstract: Clinical variables influencing outcomes in patients with atypical intradermal smooth muscle neoplasms (formerly cutaneous leiomyosarcomas): single-institution study of 95 surgical patients. Annals of Surgical Oncology, 2024. e-Pub 2024.
9. Gingrich A, Wangsiricharoen S, Torres, MB, Ravi V, Ratan R, Keung EZ, Scally CP, Lazar AJ, Wang WL, Roland CL, Hunt KK, Yu W, Torres KE. Clinical variables influencing outcomes in patients with atypical intradermal smooth muscle neoplasms (formerly cutaneous leiomyosarcomas): single-institution study of 95 surgical patients. Annals of Surgical Oncology, 2024. e-Pub 2024.
10. Pal K, Awad A, Yevich S, Kuban JD, Tam A, Huang SY, Odisio BC, Gupta S, Habibollahi P, Bishop AJ, Conley AP, Somaiah N, Araujo D, Zarzour MA, Ravin R, Roland CL, Keung EZ, Sheth RA. Safety and efficacy of percutaneous cryoablation for recurrent or metastatic soft tissue sarcoma in adult patients. AJR Am J Roentgenol, 2024. e-Pub 2024.
11. Lyu HG, Witt RG, Rajkot N, Keung EZ, Torres KE, Hunt KK, Somaiah N, Lazar AJ, Roland CL, Scally CP. Patterns of care and outcomes of patients presenting with small gastrointestinal stromal tumors at a high-volume sarcoma center 31(13):9258-9264, 2024.
12. Nassif EF, Roland CL, Keung EZ. Reflections on the value of multidisciplinary oncology training by a medical oncologist. European Journal of Surgical Oncology 49(5):1046-1047, 2023. e-Pub 2023. PMID: 36631346.
13. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. Re-excision after unplanned excision of soft tissue sarcoma is associated with high morbidity and limited pathologic identification of residual disease. Ann Surg Oncol 30(1):480-489, 2023. e-Pub 2023. PMID: 36085392.
14. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. Clinical impact of external beam radiotherapy for surgically resected primary retroperitoneal liposarcoma. Ann Surg Oncol 30(2):926-940, 2023. e-Pub 2023. PMID: 36115928.
15. Asare EA, Fisher SB, Chiang YJ, Haydu LE, Patel S, Keung EZ, Lucci A, Wargo J, Gershenwald JE, Ross MI, Lee JE. Melanoma metastatic to the adrenal gland: an update on the role of adrenalectomy in multidisciplinary management. J Surg Oncol 128(2):313-321, 2023. e-Pub 2023.
16. Noh S, Nessim C, Keung EZ, Roland CL, Strauss D, Sivarajah G, Fiore M, Biasoni D, Cioffi SPB, Mehtsun W, Cananzi FCM, Sicoli F, Quagliuolo V, Chen J, Luo C, Gladdy RA, Swallow C, Johnston W, Ford SJ, Evenden C, Tirotta F, Almond M, Nguyen L, Rutkowski P, Krotewicz M, Pennacchioli E, Cardona K, Gamboa A, Hompes D, Renard M, Kollár A, Ryser CO, Vassos N, Raut CP, Fairweather M, Krakorova DA, Quildrian S, Perhavec A, Nizri E, Farma JM, Greco SH, Vincenzi B, Lopez JAG, Solerdecoll MS, Iwata S, Fukushima S, Kim T, Tolomeo F, Snow H, Howlett-Jansen Y, Tzanis D, Nikulin M, Gronchi A, Sicklick JK, Working Group TARS. Retrospective analysis of retroperitoneal-abdominal-pelvic ganglioneuromas: An international study by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group. Ann Surg 278(2):267-273, 2023. e-Pub 2023. PMID: 35866666.
17. Thirasastr P, Lin H, Amini B, Wang WL, Cloutier JM, Nassif EF, Keung EZ, Roland CL, Feig B, Araujo D, Benjamin RS, Conley AP, Livingston JA, Ludwig J, Patel S, Ratan R, Ravi V, Zarzour MA, Zhou X, Somaiah N. Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma. Cancer Med 12(4):4282-4293, 2023. e-Pub 2023. PMID: 36151848.
18. Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZ. Practice pattern variability in the management of regional lymph node metastasis in extremity and trunk soft tissue sarcoma: A survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Annals of Surgical Oncology 30(6):3668-3676, 2023. e-Pub 2023. PMID: 36723723.
19. Witt RG, Voss RK, Lewis VO, Roland CL, Keung EZ. ASO Author Reflections: Variability in management of sarcoma lymph node metastases. Ann Surg Oncol 30(6):3677-3678, 2023. e-Pub 2023. PMID: 36749502.
20. Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. ASO Visual Abstract: Re-excision after unplanned excision of soft tissue sarcoma is associated with high morbidity and limited pathologic identification of residual disease. Ann Surg Oncol 30(1):492, 2023. e-Pub 2023. PMID: 36245056.
21. Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZ. ASO Visual Abstract: Clinical impact of external beam radiotherapy for surgically resected primary retroperitoneal liposarcoma. Ann Surg Oncol 30(2):941-942, 2023. e-Pub 2023. PMID: 36161369.
22. Keung EZ, Hunt KK, Roland CL. ASO Author Reflections: A call for consensus, collaboration and data on the role of sentinel lymph node biopsy for soft tissue sarcoma. Ann Surg Oncol 30(2):968-969, 2023. e-Pub 2023. PMID: 36394686.
23. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. ASO Visual Abstract: Sentinel lymph node biopsy for extremity and truncal soft tissue sarcomas-A systematic review of the literature. Ann Surg Oncol 30(2):970-971, 2023. e-Pub 2023. PMID: 36323987.
24. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature. Ann Surg Oncol 30(2):970-971, 2023. e-Pub 2023.
25. Anzar I, Samarakoon P, Vardaxis I, Simovski B, Fontenelle H, Meza-Zepeda LA, Keung EZ, Stratford R, Burgess M, Tawbi H, Myklebost O, Clancy T. The interplay between neoantigens and immune cells in sarcomas treated with checkpoint inhibition. Frontiers in Immunology 20(14):1226445, 2023. e-Pub 2023. PMID: 37799721.
26. Farooqi A, Yoder AK, Lin HY, Pasalic D, Erasmus J, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Roland C, Scally C, Keung EZ, Gandhi SN, Guadagnolo BA, Nguyen QN, Bishop AJ. Stereotactic ablative radiation therapy for sarcoma lung metastases: indications for treatment and guidance for patient selection. International Journal of Radiation Oncology S0360-3016(23):08023-9, 2023. PMID: 37914142.
27. Keung EZ, Krause KJ, Maxwell J, Morris CD, Crago AM, Houdek MT, Kane J, Lewis V, Callegaro D, Miller B, Lazar AJ, Gladdy R, Raut CP, Fabbri N, Al-Refaie W, Fairweather M, Wong SL, Roland CL. Sentinel lymph node biopsy for extremity and truncal sarcomas: a systematic review of the literature. Annals of Surgical Oncology 30(2):958-967, 2023. e-Pub 2023. PMID: 36307665.
28. Cass, SH, Cope, B, Bishop, AJ, Chiang, YJ, Guadagnolo, BA, Farooqi, AS, Morrison, WH, Witt, RG, Seervai, RN, Garden, AS, Fuller, C, Goepfert, RP, Ross, MI, Gershenwald, JE, Wong, MK, Aung, PP, Keung, EZ, Mitra, D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiotherapy and Oncology 188(34):109892, 2023. e-Pub 2023. PMID: 37659660.
29. Cass, SH, Tobin, J, Seo, YD, Gener-Ricos, G, Keung, EZ, Burton, EM, Davies, MA, McQuade, JL, Lazar, A, Mason, R, Millward, M, Sandhu, S, Khoo, C, Warburton, L, Guerra, VA, Haydon, A, Dearden, H, Menzies, AM, Carlino, MS, Smith, JL, Mollee, P, Burgess, M, Mapp, S, Keane, C, Atkinson, VG, Parikh, SA, Markovic, SN, Ding, W, Call, TG, Hampel, PJ, Long, GV, Wargo, J, Ferrajoli, A. Efficacy of immune checkpoint inhibitors for the treatment of advanced melanoma in patients with concomitant chronic lymphocytic leukemia. Annals of Oncology 34(9):796-805, 2023. e-Pub 2023. PMID: 37414216.
30. Witt, RG, Voss, RK, Chiang, YJ, Nguyen, S, Scally, CP, Lin, PP, Torres, KE, Moon, BS, Satcher, R, Hunt, KK, Bird, JE, Feig, BW, Lewis, VO, Roland, CL, Keung, EZ. ASO Visual Abstract: Practice pattern variability in the management of regional lymph node metastasis in extremity and trunk soft tissue sarcoma: A survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Annals of Surgical Oncology 30(6):3679-3680, 2023. e-Pub 2023. PMID: 36826618.
31. Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZ. Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer 150(12):2012-2024, 2022. e-Pub 2022. PMID: 35128664.
32. Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
33. Mitra D, Rao PK, Nagarajan P, Bishop AJ, Farooqi AS, Gershenwald JE, Wargo J, Keung EZ, Fisher SB, Amaria RN, Davies MA, Ross MI, Guadagnolo BA. Outcomes after sphincter-sparing local therapy for anorectal melanoma: 1989-2020. Pract Radiat Oncol 12(5):437-445, 2022. e-Pub 2022. PMID: 35278716.
34. Boyce-Fappiano D, Damron EP, Farooqi A, Mitra D, Conley AP, Somaiah N, Araujo D, Livingston JA, Ratan R, Keung EZ, Roland CL, Guadagnolo BA, Bishop AJ. Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions provides durable tumor control and effective palliation. Advances in Radiation Oncology 7(3):100913, 2022. e-Pub 2022. PMID: 35647398.
35. Wang Y, Ramachandran V, Sui D, Xu K, Haydu LE, Fang S, McQuade JL, Fisher SB, Lucci A, Keung EZ, Wargo J, Gershenwald JE, Ross MI, Lee JE. Evaluation of plasma IL-6 in patients with melanoma as a prognostic and checkpoint immunotherapy predictive biomarker. J Invest Dermatol 142(7):2046-2049.e3, 2022. e-Pub 2022. PMID: 34952092.
36. Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CL. Sarculator is a good model to predict survival in resected extremity and trunk sarcomas in US patients. Ann Surg Oncol, 2022. e-Pub 2022. PMID: 35224688.
37. Witt RG, Cope B, Chiang YJ, Newhook T, Lillemoe H, Tzeng CD, Chen IB, Fisher SB, Lucci A, Wargo JA, Lee JE, Ross MI, Gershenwald JE, Robinson J, Keung EZ. Utilization and evolving prescribing practice of opioid and non-opioid analgesics in patients undergoing lymphadenectomy for cutaneous malignancy. J Surg Oncol 125(4):719-729, 2022. e-Pub 2022. PMID: 34904258.
38. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. ASO Visual Abstract: Sentinel lymph node biopsy and formal lymphadenectomy for soft tissue sarcoma: A single-center experience of 86 consecutive cases. Ann Surg Oncol, 2022. PMID: 35644862.
39. Ho J, Mattei J, Tetzlaff M, Williams MD, Davies MA, Diab A, Oliva ICG, McQuade J, Patel SP, Tawbi H, Wong MK, Fisher SB, Hanna E, Keung EZ, Ross M, Weiser R, Su SY, Frumovitz M, Meyer LA, Jazaeri A, Pettaway CA, Guadagnolo BA, Bishop AJ, Mitra D, Farooqi A, Bassett R, Faria S, Nagarajan P, Amaria RN. Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma. Front Oncol 12:1001150, 2022. e-Pub 2022. PMID: 36324592.
40. DiPeri TP, Newhook TE, Day RW, Chiang YJ, Dewhurst WL, Arvide EM, Bruno ML, Scally CP, Roland CL, Katz MHG, Vauthey JN, Chang GJ, Badgwell BD, Perrier ND, Grubbs EG, Lee JE, Tzeng CD, Consortium P. A prospective feasibility study evaluating the 5x-multiplier to standardize discharge prescriptions in cancer surgery patients. Surg Open Sci 9:51-57, 2022. e-Pub 2022. PMID: 35663797.
41. Vellano CP, White MG, Andrews MC, Chelvanambi M, Witt RG, Daniele JR, Titus M, McQuade JL, Conforti F, Burton EM, Lastrapes MJ, Ologun G, Cogdill AP, Morad G, Prieto P, Lazar AJ, Chu Y, Han G, Khan MAW, Helmink B, Davies MA, Amaria RN, Kovacs JJ, Woodman SE, Patel S, Hwu P, Peoples M, Lee JE, Cooper ZA, Zhu H, Gao G, Banerjee H, Lau M, Gershenwald JE, Lucci A, Keung EZ, Ross MI, Pala L, Pagan E, Segura RL, Liu Q, Borthwick MS, Lau E, Yates MS, Westin SN, Wani K, Tetzlaff MT, Haydu LE, Mahendra M, Ma X, Logothetis C, Kulstad Z, Johnson S, Hudgens CW, Feng N, Federico L, Long GV, Futreal PA, Arur S, Tawbi HA, Moran AE, Wang L, Heffernan TP, Marszalek JR, Wargo JA. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy. Nature 606(7915):797-803, 2022. e-Pub 2022. PMID: 35705814.
42. Lazcano R, Barreto CM, Salazar R, Carapeto F, Traweek RS, Leung CH, Gite S, Mehta J, Ingram DR, Wani KM, Vu KT, Parra ER, Lu W, Zhou J, Witt RG, Cope B, Thirasastr P, Lin HY, Scally CP, Conley AP, Ratan R, Livingston JA, Zarzour AM, Ludwig J, Araujo D, Ravi V, Patel S, Benjamin R, Wargo J, Wistuba II, Somaiah N, Roland CL, Keung EZ, Solis L, Wang WL, Lazar AJ, Nassif EF. The immune landscape of undifferentiated pleomorphic sarcoma. Front Oncol 12(1008484), 2022. e-Pub 2022. PMID: 36313661.
43. Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJ. Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol 23(12):1547-1557, 2022. e-Pub 2022. PMID: 36343656.
44. Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZ. Sentinel lymph node biopsy and formal lymphadenectomy for soft tissue sarcoma: A single center experience of 86 consecutive cases. Ann Surg Oncol 29(11):7092-7100, 2022. e-Pub 2022. PMID: 35501583.
45. Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CL. Evaluating the impact of surveillance follow-up intervals in patients following resection of primary well-differentiated liposarcoma of the retroperitoneum. Ann Surg Oncol 28(1):570-575, 2021. e-Pub 2021. PMID: 32409969.
46. Mitra D, Ologun G, Keung EZ, Goepfert RP, Amaria RN, Ross MI, Gershenwald JE, Lucci A, Fisher SB, Davies MA, Lee JE, Bishop AJ, Farooqi AS, Wargo J, Guadagnolo BA. Nodal recurrence is a primary driver of early relapse for patients with sentinel lymph node positive melanoma in the modern therapeutic era. Ann Surg Oncol 28(7):3480-3489, 2021. e-Pub 2021. PMID: 33856603.
47. Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KE. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open 4(3):e210945, 2021. e-Pub 2021. PMID: 33734413.
48. Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KE. Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol 142(3):565-590, 2021. e-Pub 2021. PMID: 34283254.
49. Sloane RS, White MG, Witt RG, Banerjee A, Davies MA, Han GC, Burton E, Ajami N, Simon JM, Bernachez C, Haydu LE, Tawbi HA, Gershenwald JE, Keung EZ, Ross M, McQuade J, Amaria RN, Wani K, Lazar AJ, Woodman SE, Wang LH, Andrews MC, Wargo JA. Identification of micro-RNA-mRNA networks in melanoma and their association with PD-1 checkpoint blockade outcomes. Cancers 13(21):5301, 2021. e-Pub 2021. PMID: 34771465.
50. Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CD. Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg 220(1):140-146, 2020. e-Pub 2020. PMID: 31843190.
51. Maitituoheti M, Keung EZ, Tang M, Yan L, Alam H, Han G, Singh AK, Raman AT, Terranova C, Sarkar S, Orouji E, Amin SB, Sharma S, Williams M, Samant NS, Dhamdhere M, Zheng N, Shah T, Shah A, Axelrad JB, Anvar NE, Lin YH, Jiang S, Chang EQ, Ingram DR, Wang WL, Lazar A, Lee MG, Muller F, Wang L, Ying H, Rai K. Enhancer reprogramming confers dependence on glycolysis and IGF signaling in KMT2D mutant melanoma. Cell Rep 33(3):108293, 2020. e-Pub 2020. PMID: 33086062.
52. Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab. Clin Cancer Res 26(6):1258-1266, 2020. e-Pub 2020. PMID: 31900276.
53. Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, LeBleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, McBride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Sautès-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA. B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577(7791):549-555, 2020. e-Pub 2020. PMID: 31942075.
54. Keung EZ, Gershenwald JE. Clinicopathological features, staging, and current approaches to treatment in high-risk resectable melanoma. Journal of the National Cancer Institute 112(9):875-885, 2020. e-Pub 2020. PMID: 32061122.
55. Tzeng CW, Tran Cao HS, Roland CL, Teshome M, Bednarski BK, Ikoma N, Graham PH, Keung EZ, Scally CP, Katz MHG, Gershenwald JE, Lee JE, Vauthey JN. Surgical decision-making and prioritization for cancer patients at the onset of the COVID-19 pandemic: a multidisciplinary approach. Surg Oncol 34:182-185, 2020. e-Pub 2020. PMID: 32891326.
56. Petitprez, F, de Reyniès, A, Keung, EZ, Chen, TW, Sun, CM, Calderaro, J, Jeng, YM, Hsiao, LP, Lacroix, L, Bougoüin, A, Moreira, M, Lacroix, G, Natario, I, Adam, J, Lucchesi, C, Laizet, Y, Toulmonde, M, Burgess, MA, Bolejack, V, Reinke, DK, Wani, K, Wang, W, Lazar, A, Roland, CL, Wargo, J, Italiano, A, Sautès-Fridman, C, Tawbi, H, Fridman, WH. B cells are associated with survival and immunotherapy response in sarcoma. Nature 577(7791):556-560, 2020. e-Pub 2020. PMID: 31942077.
57. Chrisinger JSA, Al-Zaid T, Keung EZ, Leung C, Lin HY, Roland CL, Torres KE, Benjamin RS, Ingram DR, Khan S, Somaiah N, Amini B, Feig BW, Lazar AJ, Wang WL. The degree of sclerosis is associated with prognosis in well-differentiated liposarcoma of the retroperitoneum. J Surg Oncol 120(3):382-388, 2019. e-Pub 2019. PMID: 31206726.
58. Tahir SA, Gao J, Miura Y, Blando J, Tidwell RSS, Zhao H, Subudhi SK, Tawbi H, Keung E, Wargo J, Allison JP, Sharma P. Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities. Proc Natl Acad Sci U S A 116(44):22246-22251, 2019. e-Pub 2019. PMID: 31611368.
59. Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol 44(1):170-177, 2018. e-Pub 2018. PMID: 29208319.
60. Keung EZ, Ikoma N, Benjamin R, Wang WL, Lazar AJ, Feig BW. The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center. J Surg Oncol 117(8):1799-1805, 2018. e-Pub 2018. PMID: 29723411.
61. Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CL. Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer 18(1):913, 2018. e-Pub 2018. PMID: 30249211.
62. Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CL. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer 124(23):4495-4503, 2018. e-Pub 2018. PMID: 30317543.
63. Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hung KK, Wargo JA, Lazar AJ, Wang WL, Roland CL. Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology 7(2):e1385689, 2018. e-Pub 2018. PMID: 29308306.
64. Traweek RS, Lyu HG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CL. High community-level social vulnerability is associated with worse recurrence-free survival after resection of extremity and truncal soft tissue sarcoma. Annals of Surgical Oncology 31(6):4138-4147.

Abstracts

1. Keung EZ. Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience. Annual Meeting of the Connective Tissue Oncology Society.

Book Chapters

1. Cope B, Witt R, Keung EZ. Merkel cell carcinoma. In: The MD Anderson Surgical Oncology Manual. 7th. Wolters Kluwer, 2023.
2. Cope B, Witt R, Feig, R, Keung EZ. Nonmelanoma skin cancer. In: The MD Anderson Surgical Oncology Manual. 7th. Wolters Kluwer, 2023.
3. Saif A, Farooqi AS, Keung EZ. Radiation in the management of extremity sarcomas. In: Difficult Decisions in Surgery: An Evidence-Based Approach. Springer Nature, 2023.
4. Witt RG, Keung EZ. Melanoma. In: Clinical Scenarios in Surgery. 3rd edition. Lippincott Williams & Wilkins, 2023.
5. Torres MB, Keung EZ. Extremity sarcoma. In: Surgical Oncology Clerkship: A Guide for Senior Medical Students. Springer Nature, 2023.
6. Safa H, Mattei J, Bishop AJ, Keung EZ, Yadugiri S, Davies MA, Gitza Oliva IC. Melanoma. In: The MD Anderson Manual of Medical Oncology. 4th. McGraw-Hill, 2022.
7. American College of Surgeons. Extremity Sarcoma. In: Operative Standards for Cancer Surgery, Volume 3, 2022.
8. American College of Surgeons. Retroperitoneal sarcoma. In: Operative Standards for Cancer Surgery, Volume 3, 2022.
9. Keung EZ, Naylor MF. Practical management of melanoma. In: Skin Cancer Management - A Practical Approach. 2nd. Springer, 2021.
10. Keung EZ, Gershenwald JE, Kirkwood JM, Scolyer RA, Sondak V, Thompson JF, Balch CM. Melanoma prognosis and staging. In: Cutaneous Melanoma. 6th. Springer, 2020.
11. Keung EZ, Kirkwood JM, Sondak V, Wargo JA, Amaria RN. Neoadjuvant therapy. In: Cutaneous Melanoma. 6th. Springer, 2020.
12. Keung EZ, Grubbs EG. Defining the study cohort: inclusion and exclusion criteria. In: Success in Academic Surgery: Clinical Trials. Springer, 2020.
13. Keung EZ, Pollack RE, Hunt KK, Torres KE. Forequarter amputation. In: Master Techniques in Surgery: Breast Surgery. 2nd. Wolters Kluwer.
14. Keung EZ, Gershenwald JE. Clinicopathological features, staging, and current approaches to treatment in high-risk resectable melanoma. In: Cancer of the Skin. 3rd. Elsevier.